Secondary Stock OfferingsBy The Online Investor Staff, updated Fri., Jan. 22, 4:25 PM
|This Slide: #3 of 25|
Slide #3. Dyne Therapeutics, Inc. — Secondary Offering
Dyne Therapeutics, Inc. (NASDAQ:DYN)
Date of Pricing:
Price Per Share:
Secondary Offering Details:
Dyne Therapeutics, Inc. (Nasdaq: DYN), a muscle disease company focused on advancing innovative life-transforming therapeutics for people living with genetically driven diseases, today announced the pricing of an underwritten public offering of 6,000,000 shares of its common stock at a public offering price of $28.00 per share. In addition, Dyne has granted the underwriters a 30-day option to purchase up to 900,000 additional shares of common stock at the public offering price, less the underwriting discount and commissions. All of the shares are being offered by Dyne.
Dyne Therapeutics is a muscle disease company focused on advancing innovative life-transforming therapeutics for patients with genetically driven diseases. Co. offers its services in the United States.
Open the DYN Page at The Online Investor »
Strong Buy (4.00 out of 4)
(ranked higher than approx. 94% of all stocks covered)
Based on Zacks ABR data;
powered by Xignite